相关实验视频
Updated: Jan 17, 2026

05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
909
使用一种新型形状变换水凝囊减肥相关的生活质量改善: RESET研究结果 RESET研究结果
Robert F Kushner1, Jamy D Ard2, Thomas A Wadden3
1Department of Medicine, Division of Endocrinology, Metabolism, and Molecular Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. rkushner@northwestern.edu.
International journal of obesity (2005)
|September 16, 2025
概括
结合生活方式的改变,Epitomee囊显著改善了超重和肥胖的成年人的生活质量 (QOL). 这种非药物选择显示,体重减轻和QOL增长之间存在更强的联系.
科学领域:
- 肥胖研究的研究.
- 生活质量研究 生命质量研究
- 食补充剂 食补充剂 食补充剂
背景情况:
- 超重和肥胖是全球重要的健康问题.
- 生活方式干预是体重管理的基础.
- 寻求非药物辅助剂来提高治疗疗效.
研究的目的:
- 评估Epitomee囊对生活质量 (QOL) 的影响.
- 为了检查Epitomee使用,QOL和减肥之间的关联.
- 评估Epitomee作为超重/肥胖成年人的生活方式干预的辅助.
主要方法:
- 对RESET双盲,安慰剂控制试验数据的分析.
- 在24周内包括279名参与者 (BMI 27-40 kg/m2).
- 使用IWQOL-Lite-CT尺度和与体重减轻的相关性来评估QOL.
主要成果:
- 在Epitomee组,IWQOL-Lite-CT总得分和身体功能子得分显著改善.
- 两组人均从基线改善了QOL,但Epitomee显示体重减轻与QOL相关性更强.
- 数字上更高,虽然在统计学上不显著,但在Epitomee的物理和心理社会子得分中发现了改善.
结论:
- 皮托米囊,与生活方式干预一起,在超重/肥胖的成年人中提高了QOL.
- 它作为一个有前途的非药物补充剂来改善健康结果.
- 囊加强了减肥和质量生活效益之间的关系.
相关概念视频
Gastric Emptying
3.3K
Gastric emptying occurs when the stomach gradually releases chyme into the duodenum. When the stomach is distended, it triggers the release of gastrin, a hormone that promotes gastric acid secretion to aid in digestion. Additionally, stomach distension contributes to peristaltic waves that propel gastric contents toward the pyloric region. The gastroenteric reflex, on the other hand, primarily stimulates peristalsis in the intestines, facilitating the movement of contents further along the...
3.3K
Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Drug Dosing: Obese Patients
225
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
225
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
248
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
248
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
200
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
200

